Literature DB >> 9088768

Hyperleptinaemia: the missing link in the, metabolic syndrome?

M de Courten1, P Zimmet, A Hodge, V Collins, M Nicolson, M Staten, G Dowse, K G Alberti.   

Abstract

Leptin's association with fasting insulin raises the possibility that hyperleptinaemia is an additional component of the Metabolic Syndrome, or perhaps underlies the syndrome. This population-based study of Western Samoans examined the relationship of serum leptin with insulin sensitivity assessed by Homeostatic Model Assessment (HOMA) and components of the Metabolic Syndrome. Two hundred and forty subjects (114 men, 126 women), aged 28-74 years, were drawn from a study conducted in 1991. An oral glucose tolerance test indicated that 59 subjects had diabetes. Diabetic men had higher leptin levels than non-diabetic (6.0 vs 3.2 ng ml-1) but this difference was no longer significant after adjustment for BMI. Leptin levels in diabetic women (24.7 ng ml-1) non-diabetic women (22.6 ng ml-1) were not different. Leptin was strongly, positively correlated with BMI, fasting insulin and mean blood pressure after adjusting for age and sex (r > 0.43, p < 0.001), irrespective of glucose tolerance status. Linear regression models indicated that leptin was associated with insulin sensitivity independent of age, BMI, waist/hip ratio, triglycerides, HDL-cholesterol, and hypertension. Similar models were computed with mean blood pressure or triglycerides as the dependent variable, and including insulin sensitivity with the independent variables. Leptin was independently associated with mean blood pressure in men, but was not independently associated with triglycerides. Mean levels of 2-h insulin, triglycerides, LDL-cholesterol, and systolic blood pressure varied across tertiles of leptin in men after adjusting for age, BMI, and insulin sensitivity, and mean levels in the top tertile tended to be higher than in the lowest tertile. These results indicate an independent relationship between leptin and insulin sensitivity, but the equivocal results concerning associations of leptin with components of the Metabolic Syndrome make it unlikely that leptin affects these directly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088768     DOI: 10.1002/(SICI)1096-9136(199703)14:3<200::AID-DIA336>3.0.CO;2-V

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  28 in total

Review 1.  Antipsychotic-induced venous thromboembolism: a review of the evidence.

Authors:  Staffan Hägg; Olav Spigset
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

Review 3.  Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.

Authors:  Helen L Reeves; Marco Y W Zaki; Christopher P Day
Journal:  Dig Dis Sci       Date:  2016-02-26       Impact factor: 3.199

Review 4.  Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg.

Authors:  P Zimmet; G Collier
Journal:  Drugs       Date:  1999       Impact factor: 9.546

5.  Effects of leptin on expression of acyl-coenzymea: cholesterol acyltransferases-1 in cultured human monocyte-macrophages.

Authors:  Zhifeng Bai; Bei Cheng; Qizhen Yu; Changyun Li; Ping He; Xiaobo Mao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  Correlation of adiponectin and leptin with insulin resistance: a pilot study in healthy north Indian population.

Authors:  Amita Yadav; Pramila Jyoti; S K Jain; Jayashree Bhattacharjee
Journal:  Indian J Clin Biochem       Date:  2011-02-18

Review 7.  Leptin in hepatocellular carcinoma.

Authors:  Shen-Nien Wang; King-Teh Lee; Chen-Guo Ker
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

8.  The associations between serum leptin, adiponectin and intercellular adhesion molecule-1 in hypercholesterolemic patients.

Authors:  Eunju Park; Min-Jeong Shin; Namsik Chung
Journal:  Nutr Res Pract       Date:  2007-03-31       Impact factor: 1.926

Review 9.  Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?

Authors:  André J Scheen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Obesity-related cardiorenal disease: the benefits of bariatric surgery.

Authors:  Wiebke Fenske; Thanos Athanasiou; Leanne Harling; Christiane Drechsler; Ara Darzi; Hutan Ashrafian
Journal:  Nat Rev Nephrol       Date:  2013-08-06       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.